In a particularly dramatic demonstration at the Stanford
site of the pilot clinical
trial, a woman identified as «T6,» who is diagnosed with amyotrophic lateral sclerosis, was able to use BrainGate for six sessions
of a few hours each
over the
course of 42 days without any interruptions for explicit recalibration after the decoder was initialized on the first day.